GRUPO COOPERATIVO DE ESTUDIO Y TRATAMIENTO DE LAS LEUCEMIAS AGUDAS Y MIELODISPLASIAS

🇪🇸Spain
Ownership
-
Employees
-
Market Cap
-
Website

Venetoclax + Azacitidine in Patients with Acute Myeloid Leukemia

Phase 2
Not yet recruiting
Conditions
Interventions
First Posted Date
2024-10-31
Last Posted Date
2024-10-31
Lead Sponsor
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias
Target Recruit Count
29
Registration Number
NCT06668558
Locations
🇪🇸

University Hospital Son Espases, Palma de Mallorca, Baleares, Spain

🇪🇸

Hospital Son Llatzer, Palma de Mallorca, Baleares, Spain

🇪🇸

Institut Catala D oncologia Badalona, Badalona, Cataluña, Spain

and more 11 locations

Risk-adapted Therapy for Primary Acute Myeloid Leukemia

First Posted Date
2020-12-29
Last Posted Date
2023-06-27
Lead Sponsor
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias
Target Recruit Count
1034
Registration Number
NCT04687098
Locations
🇪🇸

ICO Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain

🇪🇸

Hospital Universitari Son Espases, Palma de Mallorca, Mallorca, Spain

🇪🇸

Hospital Universitari Son Llatzer, Palma de Mallorca, Mallorca, Spain

and more 12 locations

Treatment of High Risk Myelodysplastic Syndromes (MDS) Not Candidates for Allogeneic Transplantation of Hematopoietic Progenitors (ALO-HSCT)

First Posted Date
2020-10-26
Last Posted Date
2020-10-26
Lead Sponsor
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias
Target Recruit Count
150
Registration Number
NCT04602273
Locations
🇪🇸

Son Llàtzer, Palma, Islas Baleares, Spain

Risk Adapted Treatment for Primary Acute Myeloid Leukemia (AML)

First Posted Date
2012-11-08
Last Posted Date
2012-11-08
Lead Sponsor
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias
Target Recruit Count
862
Registration Number
NCT01723657
Locations
🇪🇸

ICO Hospital Universitari de Bellvitge, L'Hospitalet del Llobregat, Barcelona, Spain

🇪🇸

Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain

🇪🇸

Hospital A Coruña, A Coruña, Coruña, Spain

and more 18 locations

Risk-adapted Therapy for Adult Acute Myeloid Leukemia.

First Posted Date
2012-10-30
Last Posted Date
2012-11-01
Lead Sponsor
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias
Target Recruit Count
354
Registration Number
NCT01716793
Locations
🇪🇸

ICO Hospital Universitari de Bellvitge, L'Hospitalet del Llobregat, Barcelona, Spain

🇪🇸

Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain

🇪🇸

Hospital A Coruña, A Coruña, Coruña, Spain

and more 16 locations

Efficacy and Toxicity of Increasing Doses of Idarubicin, Cytarabine and G-CSF in Acute Myeloid Leukemia

Phase 2
Completed
Conditions
Interventions
First Posted Date
2012-10-04
Last Posted Date
2016-01-28
Lead Sponsor
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias
Target Recruit Count
48
Registration Number
NCT01700413
Locations
🇪🇸

Hospital Universitari Germans Trias I Pujol de Badalona, Badalona, Spain

🇪🇸

Hospital Clinic I Provincial de Barcelona, Barcelona, Spain

🇪🇸

Hospital Clínico Universitario de Valencia, Valencia, Spain

and more 2 locations

Prospective Study of Mylotarg and G-CSF in Acute Myeloid Leukemia Treatment

Phase 2
Completed
Conditions
Interventions
First Posted Date
2012-10-03
Last Posted Date
2021-01-27
Lead Sponsor
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias
Target Recruit Count
46
Registration Number
NCT01698879
Locations
🇪🇸

Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

🇪🇸

Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain

🇪🇸

Hospital Clinico Universitario de Salamanca, Salamanca, Spain

and more 3 locations
© Copyright 2024. All Rights Reserved by MedPath